Apion hookeri Kirby (Col., Curculionidae), a potential agent for the biological control of Tripleurospermum perforatum (Mérat) Wagenitz [=T. inodorum (L.) C. H. Schultz, Matricaria perforata Mérat, M. inodora L.] (Asteraceae, Anthemideae) in CanadaFREESE, A.Zeitschrift für Angewandte Entomologie. 1991, Vol 112, Num 1, pp 76-88, issn 0044-2240Article

A BETA -GLUCOSIDASE IN FELINE KIDNEY THAT HYDROLYZES AMYGDALIN (LAETRILE)FREESE A; BRADY RO; GAL AE et al.1980; ARCH. BIOCHEM. BIOPHYS.; USA; DA. 1980; VOL. 201; NO 2; PP. 363-368; BIBL. 21 REF.Article

Infection of cultured striatal neurons with a defective HSV-1 vector : implications for gene therapyFREESE, A; GELLER, A.Nucleic acids research. 1991, Vol 19, Num 25, pp 7219-7223, issn 0305-1048Article

Olibrus aeneus Fab. (Col. Phalacridae), a species associated with Tripleurospermum perforatum (Mérat) Wagenitz and other Anthemideae (Asteraceae) and its potential for biological controlFREESE, A; GÜNTHER, W.Zeitschrift für Angewandte Entomologie. 1991, Vol 111, Num 5, pp 499-505, issn 0044-2240Article

Infection of cultured central nervous with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli β-galactosidaseGELLER, A. I; FREESE, A.Proceedings of the National Academy of Sciences of the United States of America. 1990, Vol 87, Num 3, pp 1149-1153, issn 0027-8424, 5 p.Article

In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vectorDURING, M. J; SAMULSKI, R. J; SLADEK, J. R et al.Gene therapy (Basingstoke). 1998, Vol 5, Num 6, pp 820-827, issn 0969-7128Article

Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicityFREESE, A; FINKLESTEIN, S. P; DIFIGLIA, M et al.Brain research. 1992, Vol 575, Num 2, pp 351-355, issn 0006-8993Article

The insect complex associated with Tripleurospermum perforatum (Asteracea: Anthemideae)FREESE, A; GÜNTHER, W.Entomologia generalis. 1991, Vol 16, Num 1, pp 53-68, issn 0171-8177Article

Parkinson's disease : The case for novel treatment strategiesSTERN, M. B; FREESE, A.Experimental neurology (Print). 1997, Vol 144, Num 1, pp 2-3, issn 0014-4886Conference Paper

Extended levodopa release from a subcutaneously implanted polymer matrix in ratsSABEL, B. A; DOMINIAK, P; HAUÊSER, W et al.Annals of neurology. 1990, Vol 28, Num 5, pp 714-717, issn 0364-5134, 4 p.Article

Controlled release of dopamine from a polymeric brain implant: in vivo characterizationDURING, M. J; FREESE, A; SABEL, B. A et al.Annals of neurology. 1989, Vol 25, Num 4, pp 351-356, issn 0364-5134Article

Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan diseaseLEONE, P; JANSON, C. G; MCPHEE, S. W et al.Annals of neurology. 2000, Vol 48, Num 1, pp 27-38, issn 0364-5134Article

MR of thoracic cord compression caused by epidural extramedullary hematopoiesis in myelodysplastic syndromeDIBBERN, D. A; LOEVNER, L. A; LIEBERMAN, A. P et al.American journal of neuroradiology. 1997, Vol 18, Num 2, pp 363-366, issn 0195-6108Article

Adenovirus vector-mediated gene transfer into human epileptogenic brain slices: Prospects for gene therapy in epilepsyO'CONNOR, W. M; DAVIDSON, B. L; KAPLITT, M. G et al.Experimental neurology (Print). 1997, Vol 148, Num 1, pp 167-178, issn 0014-4886Article

Hippocampal cell distributions in temporal lobe epilepsy : A comparison between patients with and without an early risk factorO'CONNOR, W. M; MASUKAWA, L; FREESE, A et al.Epilepsia (Copenhagen). 1996, Vol 37, Num 5, pp 440-449, issn 0013-9580Article

Controlled release of dopamine from a polymeric brain implant: in vitro characterizationFREESE, A; SABEL, B. A; SALYZMAN, W. M et al.Experimental neurology (Print). 1989, Vol 103, Num 3, pp 234-238, issn 0014-4886, 5 p.Article

Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loadingDURING, M. J; HEYES, M. P; FREESE, A et al.Brain research. 1989, Vol 476, Num 2, pp 384-387, issn 0006-8993Article

Natural history of canavan disease revealed by proton magnetic resonance spectroscopy (¹H-MRS) and diffusion-weighted MRIJANSON, C. G; MCPHEE, S. W. J; LEONE, P et al.Neuropediatrics. 2006, Vol 37, Num 4, pp 209-221, issn 0174-304X, 13 p.Article

Restorative gene therapy approaches to Parkinson's diseaseFREESE, A.The Medical clinics of North America. 1999, Vol 83, Num 2, issn 0025-7125, ix,537-548 [13 p.]Article

Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin releaseFREESE, A; DURING, M. J; DAVIDSON, B. L et al.The Journal of clinical endocrinology and metabolism. 1996, Vol 81, Num 6, pp 2401-2404, issn 0021-972XArticle

Superficial siderosis of the central nervous system : magnetic resonance imaging and pathological correlation : case reportJANSS, A. J; GALETTA, S. L; FREESE, A et al.Journal of neurosurgery. 1993, Vol 79, Num 5, pp 756-760, issn 0022-3085Article

Levodopa delivery from controlled-release polymer matrix : delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in ratsSABEL, B. A; DOMINIAK, P; HAÊUSER, W et al.The Journal of pharmacology and experimental therapeutics. 1990, Vol 255, Num 2, pp 914-922, issn 0022-3565, 9 p.Article

Multi-site partitioned delivery of human tyrosine hydroxylase gene with phenotypic recovery in Parkinsonian ratsLEONE, P; MCPHEE, S. W. J; JANSON, C. G et al.Neuroreport (Oxford). 2000, Vol 11, Num 6, pp 1145-1151, issn 0959-4965Article

Analysis of harvest morbidity and radiographic outcome using autograft for anterior cervical fusionSCHNEE, C. L; FREESE, A; WEIL, R. J et al.Spine (Philadelphia, PA. 1976). 1997, Vol 22, Num 19, pp 2222-2227, issn 0362-2436Article

Prospects for gene therapy in Parkinson's diseaseFREESE, A; STERN, M; KAPLITT, M. G et al.Movement disorders. 1996, Vol 11, Num 5, pp 469-488, issn 0885-3185Conference Paper